These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 19131665)

  • 1. Direct subunit-dependent multimodal 5-hydroxytryptamine3 receptor antagonism by methadone.
    Deeb TZ; Sharp D; Hales TG
    Mol Pharmacol; 2009 Apr; 75(4):908-17. PubMed ID: 19131665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 5-HT3B subunit affects high-potency inhibition of 5-HT3 receptors by morphine.
    Baptista-Hon DT; Deeb TZ; Othman NA; Sharp D; Hales TG
    Br J Pharmacol; 2012 Feb; 165(3):693-704. PubMed ID: 21740409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subunit-dependent modulation of the 5-hydroxytryptamine type 3 receptor open-close equilibrium by n-alcohols.
    Rüsch D; Musset B; Wulf H; Schuster A; Raines DE
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1069-74. PubMed ID: 17360702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. General anesthetic-induced channel gating enhancement of 5-hydroxytryptamine type 3 receptors depends on receptor subunit composition.
    Solt K; Stevens RJ; Davies PA; Raines DE
    J Pharmacol Exp Ther; 2005 Nov; 315(2):771-6. PubMed ID: 16081679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introduction of the 5-HT3B subunit alters the functional properties of 5-HT3 receptors native to neuroblastoma cells.
    Stewart A; Davies PA; Kirkness EF; Safa P; Hales TG
    Neuropharmacology; 2003 Feb; 44(2):214-23. PubMed ID: 12623220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-expression of the 5-HT3B serotonin receptor subunit alters the biophysics of the 5-HT3 receptor.
    Hapfelmeier G; Tredt C; Haseneder R; Zieglgänsberger W; Eisensamer B; Rupprecht R; Rammes G
    Biophys J; 2003 Mar; 84(3):1720-33. PubMed ID: 12609874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bupropion Inhibits Serotonin Type 3AB Heteromeric Channels at Clinically Relevant Concentrations.
    Stuebler AG; Jansen M
    Mol Pharmacol; 2020 Mar; 97(3):171-179. PubMed ID: 31871303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of fentanyl-like opioids and hydromorphone on human 5-HT3A receptors.
    Wittmann M; Schaaf T; Peters I; Wirz S; Urban BW; Barann M
    Anesth Analg; 2008 Jul; 107(1):107-12. PubMed ID: 18635474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiemetics of the 5-hydroxytryptamine 3A antagonist class inhibit muscle nicotinic acetylcholine receptors.
    Paul M; Callahan R; Au J; Kindler CH; Yost CS
    Anesth Analg; 2005 Sep; 101(3):715-721. PubMed ID: 16115980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticancer drug irinotecan inhibits homomeric 5-HT3A and heteromeric 5-HT3AB receptor responses.
    Nakamura Y; Ishida Y; Yamada T; Shimada S
    Biochem Biophys Res Commun; 2011 Nov; 415(2):416-20. PubMed ID: 22044840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of block by fluoxetine of 5-hydroxytryptamine3 (5-HT3)-mediated currents in NCB-20 neuroblastoma cells.
    Choi JS; Choi BH; Ahn HS; Kim MJ; Rhie DJ; Yoon SH; Min DS; Jo YH; Kim MS; Sung KW; Hahn SJ
    Biochem Pharmacol; 2003 Dec; 66(11):2125-32. PubMed ID: 14609737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the voltage-dependent Ca2+ block of serotonin 5-HT3 receptors: a critical role of intracellular phosphates.
    Noam Y; Wadman WJ; van Hooft JA
    J Physiol; 2008 Aug; 586(15):3629-38. PubMed ID: 18566001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct effects of riluzole on 5-hydroxytryptamine (5-HT)3 receptor-activated ion currents in NCB-20 neuroblastoma cells.
    Kim KJ; Cho HS; Choi SJ; Jeun SH; Kim SY; Sung KW
    J Pharmacol Sci; 2008 May; 107(1):57-65. PubMed ID: 18460823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of recognition loops B and D in the activation of human 5-HT₃ receptors by 5-HT and meta-chlorophenylbiguanide.
    Michaelson SD; Paulsen IM; Kozuska JL; Martin IL; Dunn SM
    Neuropharmacology; 2013 Oct; 73():398-403. PubMed ID: 23810831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Competitive antagonism of the mouse 5-hydroxytryptamine3 receptor by bisindolylmaleimide I, a "selective" protein kinase C inhibitor.
    Coultrap SJ; Sun H; Tenner TE; Machu TK
    J Pharmacol Exp Ther; 1999 Jul; 290(1):76-82. PubMed ID: 10381762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of stereoisomers of zacopride to analyze actions of 5-hydroxytryptamine on enteric neurons.
    Wade PR; Mawe GM; Branchek TA; Gershon MD
    Am J Physiol; 1991 Jan; 260(1 Pt 1):G80-90. PubMed ID: 1987811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct activation by dopamine of recombinant human 5-HT1A receptors: comparison with human 5-HT2C and 5-HT3 receptors.
    Oz M; Zhang L; Rotondo A; Sun H; Morales M
    Synapse; 2003 Dec; 50(4):303-13. PubMed ID: 14556235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bicuculline antagonizes 5-HT(3A) and alpha2 glycine receptors expressed in Xenopus oocytes.
    Sun H; Machu TK
    Eur J Pharmacol; 2000 Mar; 391(3):243-9. PubMed ID: 10729364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular cloning and pharmacological characterization of serotonin 5-HT(3A) receptor subtype in dog.
    Jensen TN; Nielsen J; Frederiksen K; Ebert B
    Eur J Pharmacol; 2006 May; 538(1-3):23-31. PubMed ID: 16647053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct inhibition of 5-hydroxytryptamine3 receptors by antagonists of L-type Ca2+ channels.
    Hargreaves AC; Gunthorpe MJ; Taylor CW; Lummis SC
    Mol Pharmacol; 1996 Nov; 50(5):1284-94. PubMed ID: 8913360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.